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Fifty years ago Jacques Miller devised a technique to thymec-
tomize neonatal mice to explore the hypothesis that the thymus
played a role in the development of immunity. He found that if
thymectomized by day 3 postpartum, the mice would develop
normally for the first month, but thereafter they underwent a
runting syndrome similar to that observed during Graft vs. Host
Disease (GvHD) (Miller, 1962). During the second month of
life the mice would lose weight and suffer from a dermatitis
and generalized lymphadenopathy and splenomegaly followed by
premature death. A more detailed examination of the immune
system revealed that early after thymectomy the mice were lym-
phopenic and immunocompromized, unable to reject allogeneic
or even xenogeneic skin grafts, and incapable of generating anti-
bodies to routine antigens. Miller correctly interpreted his find-
ings as evidence that the thymus appeared to be critical in the
first few weeks of life for the development of a mature func-
tional immune system, but he did not speculate on the cause
of the later enigmatic development of lymphoproliferation and
apparent autoimmunity.
Twenty years after Miller’s seminal observations, Shimon
Sakaguchi reported that the lymphoproliferative/autoimmune
diseases of immunocompromized day-3 thymectomized
(d3Tx) could be transferred to neonatal mice with
Thy-1+, Lyt-1+, Ly-23- splenocytes from the afflicted ani-
mals (Sakaguchi et al., 1982b). Furthermore, the autoimmune
syndrome that developed in d3Tx mice could be completely pre-
vented by a single intraperitoneal injection of Thy-1+, Lyt-1+,
Lyt-23- splenocytes or thymocytes taken from normal adult
mice (Sakaguchi et al., 1982a). Prior to these experiments,
alloantisera reactive with Lyt-1 were thought to mark the helper
T cell subset (Th cells) (Cantor and Boyse, 1975; Kisielow et al.,
1975). However, Lyt-1 alloantigens were subsequently found on
all T cells to a varying degree and therefore could not be the
murine equivalent to the T4 (CD4) determinants that specifically
identified human Th cells, restricted to antigen recognition with
MHC class II molecules (Reinherz et al., 1979b; Ledbetter et al.,
1980).
Additional progress in the molecular understanding of the reg-
ulation of adaptive immunity was required before it was possible
to make further progress in the dissection of these phenomena,
especially the molecular mechanism(s) responsible for the appar-
ent suppressive activities of mature T cells vs. neonatal T cells.
Thus, T cell clones (Baker et al., 1979) were necessary to define the
molecular nature of the T cell antigen receptor (TCR) complex,
including the roles of the accessory molecules CD4 and CD8
as facilitating recognition of antigenic peptides bound to MHC
class II and class I, respectively (Reinherz et al., 1979a, 1980a),
as well as the role of the CD3 molecules as triggers of antigen
recognition (Reinherz et al., 1980b), found to be mediated by
the disulfide-linked heterodimeric α and β chains (Meuer et al.,
1983). Thus, antigen-specific recognition by the TCR complex
leads to the expression of antigen-non-specific cytokines, such
as interleukin-2 (IL-2) and its receptors (Meuer et al., 1984), so
that the tempo, magnitude, and duration of immune responses
came to be understood to depend upon antigen non-specific
hormone-like molecules (Cantrell and Smith, 1984; Smith, 1988).
Inherent in these concepts was the demonstration that IL-2 inter-
acts with specific receptors that satisfied all of the characteristics
of true hormone receptors, i.e., high affinity, stereospecificity,
saturability, and physiologic relevance (Robb et al., 1981).
Given these findings, a totally unexpected result of the dele-
tion of the IL-2 gene was reported by Ivan Horak’s group (Schorle
et al., 1991). Mice developing with the total absence of IL-2 were
remarkably similar to Miller’s neonatal thymectomized mice.
Intitially, the IL-2(−/−) mice grew normally and as expected
were immunocompromized (Kundig et al., 1993). However, as
they aged there occurred a lymphoroliferative syndrome with
the accumulation of activated T cells in secondary lymphoid
organs and even invasion of non-lymphoid organs that culmi-
nated in premature death due to autoimmune hemolytic anemia
and inflammatory bowel disease (Horak et al., 1995; Sadlack et al.,
1995).
Concurrent with these publications, Sakaguchi and his col-
leagues reported that a critical subset of CD4+ T cells that express
the IL-2R α-chain, ∼10% of mature peripheral CD4+ T cells,
could prevent autoimmune diseases of immunodeficient nu/nu
mice injected with immunocompetent CD4+ T cells depleted
of IL-2Rα+ cells (Sakaguchi et al., 1995). Subsequently, the
inhibitory molecule CTLA-4 was found to play a major role in
the regulatory function of CD4+IL-2Rα+ cells (Takahashi et al.,
2000).
The finding that CD4+IL-2Rα+CTLA-4+ cells express the
transcriptional regulator FOXP3 helped to explain the pheno-
type of regulatory T cells (T-Regs) (Fontenot et al., 2003; Hori
et al., 2003; Walker et al., 2003). Moreover, IL-2 was found to
be required for FOXP3 expression and the normal development
of FOXP3+ cells (Zorn et al., 2006; Burchill et al., 2007). Also,
FOXP3 was found to inhibit IL-2 expression, which accounted
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for T-Reg anergy, and led to the conclusion that IL-2 activates a
negative-feedback loop via FOXP3 that limits T cell proliferative
expansion during an immune reaction (Popmihajlov and Smith,
2008). However, the FOXP3-induced increase in the expression
of both CTLA-4 and IL-2Rα chains did not immediately translate
into mechanisms that could readily explain immunosuppression
(Wu et al., 2006).
A seminal breakthrough in understanding the molecular
mechanisms of T-Reg immunosuppression was contributed by
Pushpa Pandiyan and Michael Leonardo and their co-workers,
who detailed how T-Reg cells, incapable of producing IL-2,
are very efficient in binding and degrading IL-2, thereby lead-
ing to cytokine deprivation apoptosis of T-Effector cells (T-Eff)
(Pandiyan et al., 2007), as well as T-Regs themselves (Pandiyan
and Lenardo, 2008).
Thomas Hofer’s group (Busse et al., 2010) and independently,
Gregoire Altan-Bonnet’s group (Feinerman et al., 2010), using
both theoretical and experimental approaches, reported that dur-
ing an immune response there is a competition for IL-2 between
T-Regs and activated effector T cells (T-Effs). Moreover, Altan-
Bonnet showed that the IL-2 up-regulation of the IL-2Rα+ chain,
first noted soon after the IL-2Rα+ chain was discovered (Leonard
et al., 1982; Smith and Cantrell, 1985), can result in a 1000-fold
increase in the affinity of IL-2 binding to the trimeric IL-2R.
Consequently, T-Regs can rapidly respond to the initial IL-2 pro-
duced by T-Effs, and up-regulate IL-2Rα+ chains, which will
favor IL-2 binding and degradationmuchmore efficiently than T-
Effs, which require several hours before they can express IL-2Rα+
chains upon antigen stimulation. Thus, the “strength” of the ini-
tial antigenic stimulation, which determines the amount of IL-2
produced initially, can be overcome by T-Regs when the antigens
are of low affinity or at low concentrations (i.e., “weak”), but can-
not be competed successfully by T-Regs if the antigenic stimulus is
“strong” (i.e., high affinity or at high concentrations). Assuming
autoantigens to be “weak” and non-self antigens to be “strong,”
this system could account for self–non-self recognition.
With this brief chronology as background, readers will find
many of the contributions to this volume remarkable, in that
many of the field leaders, but not all, have reached a consensus
that the major molecular mechanism whereby T-Regs suppress
T-Effs revolves around their capacity to regulate the availability of
IL-2 as well as other cytokines.
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